Hani Hassoun

9.0k citations

160 papers · 3.7k indexed · h-index 32

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
Internal Medicine top 2%

Papers in

Hematology 113
- Multiple Myeloma Research and Treatments 103
- Chronic Myeloid Leukemia Treatments 15
Genetics 30
- Myeloproliferative Neoplasms: Diagnosis and Treatment 14

Co-authors: Heather Landau J Palek Raymond L. Comenzo Elyn Riedel Darren R. Feldman Alexander M. Lesokhin Sergio Giralt Madhav V. Dhodapkar
Journals: Blood (66 papers)Journal of Clinical Oncology (23 papers)Biology of Blood and Marrow Transplantation (10 papers)British Journal of Haematology (6 papers)Bone Marrow Transplantation (5 papers)
Partner nations: United States France Spain

In The Last Decade

Hani Hassoun

149 papers receiving 3.6k citations

Peers

Countries citing papers authored by Hani Hassoun

Since Specialization

Citations

This map shows the geographic impact of Hani Hassoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hani Hassoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hani Hassoun more than expected).

Fields of papers citing papers by Hani Hassoun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hani Hassoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hani Hassoun. The network helps show where Hani Hassoun may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hani Hassoun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hani Hassoun Line = papers co-authored together Hani Hassoun links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	T-Cell Exhaustion Signature Predicts Early Relapse after Autologous Stem Cell Transplant for Multiple Myeloma: BMT CTN 0702 Secondary Immune Analysis Blood ·Екатерина Юрьевна Рожина Екатерина Юрьевна, Andriy Derkach, Billel Gasmi, Theodora Anagnostou, Heather Landau, Oscar Lahoud, Michael Scordo, Gunjan L. Shah, Hani Hassoun, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Sham Mailankody, Urvi A. Shah, Carlyn Tan, Saad Z. Usmani, Sergio Giralt, Alexander M. Lesokhin, David J. Chung	2023	1
2	P-486 Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma Clinical Lymphoma Myeloma & Leukemia ·Liebhold, Ross Firestone, Andriy Derkach, Kylee Maclachlan, Malin Hultcrantz, Sham Mailankody, Oscar Lahoud, Heather Landau, Chiou-Yan Lai, Gunjan L. Shah, Michael Scordo, Hani Hassoun, Alexander M. Lesokhin, Sergio Giralt, Neha Korde, Saad Z. Usmani, Carlyn Tan, Urvi A. Shah	2023	1
3	Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma Clinical Cancer Research ·Malin Hultcrantz, Even H. Rustad, Venkata Yellapantula, Allison P. Jacob, 伊藤直哉, Neha Korde, Sham Mailankody, Alexander M. Lesokhin, Hani Hassoun, Eric L. Smith, Oscar Lahoud, Heather Landau, Gunjan L. Shah, Michael Scordo, David J. Chung, Sergio Giralt, Elli Papaemmanuil, Ola Landgren	2022	1
4	A Pilot Plant-Based Dietary Intervention in Overweight and Obese Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma- the Nutrition Prevention (NUTRIVENTION) Study Blood ·Urvi A. Shah, Liu Jian-l, 裕一平田, Karen Blackmon, M. Shuntov, Andriy Derkach, Sham Mailankody, Neha Korde, Carlyn Tan, Malin Hultcrantz, Sydney X. Lu, 裕司中野, Hani Hassoun, Anita D’Souza, Sergio Giralt, Neil M. Iyengar, Ola Landgren, Marcel R.M. van den Brink, Alexander M. Lesokhin	2021	0
5	A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202) American Journal of Hematology ·Peter M. Voorhees, Vera J. Suman, Sascha A. Tuchman, Jacob P. Laubach, Hani Hassoun, Yvonne A. Efebera, Flora Mulkey, Marta Martínez‐Casales, Tingjian Ge, Gracienne Gracienne, Philip L. McCarthy, Paul G. Richardson	2021	17
6	INCREMENTAL VALUE OF GLS FOR CLASSIFICATION OF PROGNOSIS IN PATIENTS WITH ADVANCED LIGHT CHAIN (AL) AMYLOIDOSIS Journal of the American College of Cardiology ·Hillary Page Ive, Katherine Lee Chuy, Sumrit Satija, Heather Landau, J. Rouvier, Hani Hassoun, Carol L. Chen, Anthony F. Yu, Richard M. Steingart, Jennifer E. Liu	2020	1
7	Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis JACC CardioOncology ·Katherine Lee Chuy, Esther Drill, Sumrit Satija, Heather Landau, Hani Hassoun, Hillary Page Ive, Carol L. Chen, Anthony F. Yu, Richard M. Steingart, Jennifer E. Liu	2020	34
8	Cardiac ALL: Most Unusual Occurrence of Lenalidomide-associated Acute Lymphoblastic Leukemia with Subsequent Cardiac Involvement Cureus ·Kadkhodapoor, Hani Hassoun, Donatella Albini, Peter A. Kouides	2019	3
9	Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis Biology of Blood and Marrow Transplantation ·Heather Landau, Oscar Lahoud, Sean M. Devlin, Nikoletta Lendvai, David J. Chung, Ahmet Doǧan, Ola Landgren, Sergio Giralt, Hani Hassoun	2019	11
10	Treatment Outcomes in Monoclonal Immunoglobulin Deposition Disease (MIDD): A Two Center Experience Blood ·Matthew J. Pianko, Susan M. Breitenstein, Jessica Flynn, Sean M. Devlin, Sh. Bahadoran, Adriana Rossi, Steven Salvatore, Heather Landau, Nikoletta Lendvai, Eric L. Smith, Neha Korde, Sham Mailankody, Alexander M. Lesokhin, Malin Hultcrantz, David J. Chung, Sergio Giralt, Ola Landgren, Hani Hassoun	2018	0
11	Multiple myeloma with simultaneous cutaneous and central nervous system involvement Clinical Case Reports ·James Nguyen, Hani Hassoun	2018	2
12	Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation Journal of the American Society of Echocardiography ·Catherine Neal, Heather Landau, Elyn Riedel, Milagros Gonzales-Miñán, Anthony F. Yu, Hani Hassoun, Carol L. Chen, Richard M. Steingart, Jennifer E. Liu	2017	39
13	Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study Bone Marrow Transplantation ·實加納, Brian C. Black, Sean M. Devlin, S. Thameur, Jill Vanak, Heather Landau, David J. Chung, Nikoletta Lendvai, Alexander M. Lesokhin, Neha Korde, Lilian Reich, Ola Landgren, Sergio Giralt, Hani Hassoun	2016	38
14	A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma Blood ·Nikoletta Lendvai, Patrick Hilden, Sean M. Devlin, Heather Landau, Hani Hassoun, Alexander M. Lesokhin, J. Calker, Pravin Kore, Guenther Koehne, David J. Chung, Wendy Schaffer, Sergio Giralt	2014	65
15	Clonal Plasma Cell Pathophysiology and Clinical Features of Disease Are Linked to Clonal Plasma Cell Expression of Cyclin D1 in Systemic Light-Chain Amyloidosis Clinical Lymphoma Myeloma & Leukemia ·Ping Zhou, James E. Hoffman, Heather Landau, Hani Hassoun, Lakshmanan K. Iyer, Raymond L. Comenzo	2011	24
16	Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation Leukemia ·Raymond L. Comenzo, Hani Hassoun, Tarun Kewalramani, Virginia M. Klimek, Madhav V. Dhodapkar, Lilian Reich, Julie Teruya‐Feldstein, Martin Fleisher, D Filippa, Stephen D. Nimer	2005	9
17	Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial Bone Marrow Transplantation ·Sunil Gupta, Ping Zhou, Hani Hassoun, Tarun Kewalramani, Lilian Reich, 伟勇吴, Lisa A. Drake, Virginia M. Klimek, Madhav V. Dhodapkar, Julie Teruya‐Feldstein, Cyrus V. Hedvat, Nagesh Kalakonda, Martin Fleisher, D Filippa, Jing Qin, Stephen D. Nimer, Raymond L. Comenzo	2005	15
18	β‐Spectrin S^ta Bárbara: a novel frameshift mutation in hereditary spherocytosis associated with detectable levels of mRNA and a germ cell line mosaicism British Journal of Haematology ·Daniela S. Daniela Sanchez Bassères, Adriana Silva Santos Duarte, Hani Hassoun, Fernando Ferreira Costa, Sara T. Olalla Saad	2001	7
19	A novel mobile element inserted in the alpha spectrin gene: spectrin dayton. A truncated alpha spectrin associated with hereditary elliptocytosis. Journal of Clinical Investigation ·Hani Hassoun, Thérèsa L. Coetzer, John Vassiliadis, Kenneth E. Sahr, 香奈藤本, Sara Teresinha Olalla Saad, Dhalla S Rizwan, J Palek	1994	33
20	Haemangioblastoma of the brain Acta Neurochirurgica ·Claire Dingremont, Mario Baldini, Hani Hassoun, R Vigouroux, J Paillas	1985	2

About Hani Hassoun

Hani Hassoun is a scholar working on Hematology, Genetics, Internal Medicine, Oncology and Molecular Biology, having authored 160 papers that have together received 3.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (103 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (34 papers), Protein Degradation and Inhibitors (29 papers), Cancer Treatment and Pharmacology (21 papers), Peptidase Inhibition and Analysis (15 papers), Chronic Myeloid Leukemia Treatments (15 papers), Erythrocyte Function and Pathophysiology (14 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers). The work is most often cited by research in Hematology (1.6k citations), Internal Medicine (242 citations), Genetics (574 citations), Oncology (1.2k citations) and Immunology (617 citations). Hani Hassoun has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Heather Landau, J Palek, Raymond L. Comenzo, Elyn Riedel, Darren R. Feldman, Alexander M. Lesokhin, Sergio Giralt, Madhav V. Dhodapkar, Nancy Liu and D. Chang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, British Journal of Haematology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact